Raphaël Thuillet Selected Research

Epoxide Hydrolases

1/2023

Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raphaël Thuillet Research Topics

Disease

17	Pulmonary Hypertension 05/2023 - 04/2014
11	Pulmonary Arterial Hypertension 09/2023 - 04/2015
11	Hypoxia (Hypoxemia) 05/2023 - 01/2016
8	Vascular Remodeling 09/2023 - 01/2016
6	Fibrosis (Cirrhosis) 04/2024 - 01/2021
5	Inflammation (Inflammations) 12/2023 - 04/2015
2	Disease Progression 04/2024 - 02/2017
2	Systemic Scleroderma (Systemic Sclerosis) 12/2023 - 08/2023
2	Lung Diseases (Lung Disease) 05/2023 - 01/2020
2	Right Ventricular Hypertrophy 05/2023 - 01/2019
2	Familial Primary Pulmonary Hypertension 07/2021 - 01/2020
1	Hepatopulmonary Syndrome 04/2024
1	Portal Hypertension 04/2024
1	Type 2 Diabetes Mellitus (MODY) 05/2023
1	Neuralgia (Stump Neuralgia) 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Genomic Instability 01/2022
1	Hypertension (High Blood Pressure) 11/2021
1	Heart Failure 11/2021
1	Hypertrophy 01/2021
1	Pneumonia (Pneumonitis) 01/2020
1	Cardiomegaly (Heart Hypertrophy) 01/2020
1	Idiopathic Pulmonary Fibrosis 01/2019
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2018
1	Neoplasms (Cancer) 12/2018
1	Prostatic Neoplasms (Prostate Cancer) 12/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2018
1	Pleural Effusion (Pleural Effusions) 01/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2016

Drug/Important Bio-Agent (IBA)

9	MonocrotalineIBA 05/2023 - 10/2015
3	LeptinIBA 09/2023 - 04/2015
3	CollagenIBA 08/2023 - 12/2018
3	Dasatinib (BMS 354825)FDA Link 01/2022 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
2	Growth Differentiation Factor 2IBA 04/2024 - 01/2019
2	Leptin ReceptorsIBA 09/2023 - 01/2016
2	Semaxinib (SU5416)IBA 01/2023 - 01/2020
2	Therapeutic UsesIBA 01/2020 - 01/2019
2	Macrophage Migration-Inhibitory FactorsIBA 12/2018 - 12/2018
1	RNA (Ribonucleic Acid)IBA 12/2023
1	Arsenic Trioxide (Trisenox)FDA Link 12/2023
1	Ubiquitin-Specific ProteasesIBA 09/2023
1	Chimeric Antigen ReceptorsIBA 08/2023
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 05/2023
1	AMP-Activated Protein KinasesIBA 05/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2023
1	Metformin (Glucophage)FDA LinkGeneric 05/2023
1	Urea (Carbamide)FDA LinkGeneric 01/2023
1	Epoxide HydrolasesIBA 01/2023
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2023
1	Epoxy Compounds (Epoxides)IBA 01/2023
1	Activins (Activin)IBA 01/2023
1	finerenoneIBA 10/2022
1	Mineralocorticoid Receptor AntagonistsIBA 10/2022
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 10/2022
1	Hypochlorous Acid (Hypochlorite)IBA 01/2022
1	HydantoinsIBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	Platelet-Derived Growth FactorIBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2022
1	Fibrillar CollagensIBA 01/2022
1	LysophospholipidsIBA 11/2021
1	Angiotensin IIIBA 11/2021
1	Bosentan (Tracleer)FDA Link 01/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021
1	Uric Acid (Urate)IBA 01/2021
1	urate transporterIBA 01/2021
1	Xanthine OxidaseIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2020
1	plerixafor FDA Link 01/2020
1	Connexin 43 (Connexin43)IBA 01/2020
1	LIT-927IBA 01/2020
1	Chemokine ReceptorsIBA 01/2020
1	Chalcone (Benzalacetophenone)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Vasoconstrictor AgentsIBA 01/2019
1	Vasodilator Agents (Vasodilators)IBA 01/2019
1	pirfenidoneIBA 01/2019
1	AntibodiesIBA 01/2019
1	Endothelin-1 (Endothelin 1)IBA 01/2019
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2019
1	Activin Receptors (Activin Receptor)IBA 01/2019
1	ApelinIBA 01/2019
1	Bone Morphogenetic Protein ReceptorsIBA 01/2019
1	AdrenomedullinIBA 01/2019
1	LigandsIBA 01/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2018
1	BenzoxazolesIBA 12/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016

Therapy/Procedure

5	Therapeutics 01/2022 - 04/2015
1	Ligation 04/2024
1	Oral Administration 01/2023
1	Injections 01/2022
1	Denervation 02/2017